Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
By M. Aricò, M. Valsecchi, B. Camitta, M. Schrappe, J. Chessells, A. Baruchel, P. Gaynon, L. Silverman, G. Janka-Schaub, W. Kamps and 2 more. New England Journal of Medicine, 2000
601 citations recorded by the source corpus.
Subfields: Hematology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/18a542ba3fa191e2b7b17c6ec046afa52a0dacee
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Acute Lymphoblastic Leukemia in Children (2013, unknown): “There is no consensus on the indications for transplantation in child‐ hood ALL in first complete remission (CR1) among major international study groups.”
- NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information (2007, background): “This detailed molecular information can be used by pathologists and hematologists to establish the molecular identity of a new patient, to monitor the response to treatment, and to detect minimal residual disease [26–38].”
- Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. (2002, background): “…we were able to separate T-ALL (43 cases), E2A- PBX1 (27 cases), TEL-AML1 (79 cases), and hyperdiploid Ͼ50 (64 improve outcome for patients with the former leukemia subtype (Pui et al., 1991; Heerema et al., 1999; Arico et al., 2000; Biondi cases) from the remaining ALL subtypes (114 cases).”